Effects of Procedural Discomfort and Expectation of Benefit on Therapy Continuation in Chronic Migraine Patients Treated With OnabotulinumtoxinA.

CONCLUSIONS: In the usual care setting, PD and EOB are not significantly associated with therapy continuation in patients receiving initial treatment with BTX for the prevention of CM. However, after considering sex, age, year of treatment, and number of previous headache preventives attempted, we found that female patients had twice the likelihood of continuing with BTX therapy compared to male patients with CM.
PMID: 33128398 [PubMed - as supplied by publisher]

Source: Headache - October 31, 2020 Category: Neurology Authors: Anderson CC, Ray CA, Butler MR, Darken RS Tags: Headache Source Type: research